Area of research
Oncology · Materials Chemistry
Research interest
Research interests include Prodrug, Immunogenic cell death, Programmed cell death, Chemistry, Cisplatin, and Cancer research.
Multitargeting Pt(IV) Derivatives of Cisplatin or Oxaliplatin Inhibit Tumor Growth in Mice without Inducing Neuropathic Pain
A Triple Threat Against Ovarian Cancer: Os(II)‐Pt(IV)‐Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction
Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death
Three Is Better than One: A Multimetal Complex that Triggers Immunogenic Cell Death
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy